Translate this page to:
In JoVE (1)
- Systemic and Local Drug Delivery for Treating Diseases of the Central Nervous System in Rodent Models
Other Publications (3)
Articles by Laura Serwer in JoVE
Systemic and Local Drug Delivery for Treating Diseases of the Central Nervous System in Rodent Models
Laura Serwer, Rintaro Hashizume, Tomoko Ozawa, C. David James
Department of Neurological Surgery, University of California, San Francisco - UCSF
Thorough preclinical testing of drugs that act in the central nervous system often involves assessing and comparing drug biodistribution in association with specific routes of administration. Here, three commonly used methods of systemic delivery (intravenous, intraperitoneal, and oral) as well as a method for local delivery (convection-enhanced delivery) are demonstrated in mice.
Other articles by Laura Serwer on PubMed
PLoS Biology. Jan, 2010 | Pubmed ID: 20087412
Investigation of Intravenous Delivery of Nanoliposomal Topotecan for Activity Against Orthotopic Glioblastoma Xenografts
Neuro-oncology. Dec, 2011 | Pubmed ID: 21954443
Achieving effective treatment outcomes for patients with glioblastoma (GBM) has been impeded by many obstacles, including the pharmacokinetic limitations of antitumor agents, such as topotecan (TPT). Here, we demonstrate that intravenous administration of a novel nanoliposomal formulation of TPT (nLS-TPT) extends the survival of mice with intracranial GBM xenografts, relative to administration of free TPT, because of improved biodistribution and pharmacokinetics of the liposome-formulated drug. In 3 distinct orthotopic GBM models, 3 weeks of biweekly intravenous therapy with nLS-TPT was sufficient to delay tumor growth and significantly extend animal survival, compared with treatment with free TPT (P ≤ .03 for each tumor tested). Analysis of intracranial tumors showed increased activation of cleaved caspase-3 and increased DNA fragmentation, both indicators of apoptotic response to treatment with nLS-TPT. These results demonstrate that intravenous delivery of nLS-TPT is a promising strategy in the treatment of GBM and support clinical investigation of this therapeutic approach.
Challenges in Drug Delivery to Tumors of the Central Nervous System: An Overview of Pharmacological and Surgical Considerations
Advanced Drug Delivery Reviews. Jan, 2012 | Pubmed ID: 22306489
The majority of newly diagnosed brain tumors are treated with surgery, radiation, and the chemotherapeutic temozolomide. Development of additional therapeutics to improve treatment outcomes is complicated by the blood-brain barrier (BBB), which acts to protect healthy tissue from chemical insults. The high pressure found within brain tumors adds a challenge to local delivery of therapy by limiting the distribution of bolus injections. Here we discuss various drug delivery strategies, including convection-enhanced delivery, intranasal delivery, and intrathecal delivery, as well as pharmacological strategies for improving therapeutic efficacy, such as blood-brain barrier disruption.